The latest development for AdjuCor came in the form of a €2.50M grant investment on 03 February 2023, from the European Innovation Council and SMEs Executive Agency. This funding will likely play a crucial role in advancing AdjuCor's game-changing approach to treating advanced heart failure.
General Information
BounceWatch is an independent company data service, not affiliated with AdjuCor GmbH. To contact AdjuCor GmbH, visit adjucor.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does AdjuCor GmbH compare?
A PDF of AdjuCor GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting AdjuCor GmbH soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Germany Market
Health Care
About AdjuCor GmbH
Business keywords: heart failure treatment, mechanical circulatory support, advanced heart failure, minimally invasive, revolutionary technology, uni- or biventricular support, blood contact avoidance, high-tech, Germany-based company
Funding Rounds & Investors (4)
View AllAdjuCor GmbH Alternatives & Competitors
View All AlternativesPresenting the ModulHeart. Low-risk heart support for patients with advanced heart failure
Innovating heart failure treatment with minimally-invasive micro-pumps for enhanced long-term circul...
A cardiac medical device company determined to improve the lives of heart failure patients through C...
FAQ About AdjuCor GmbH
Source: BounceWatch company record for AdjuCor GmbH, https://bouncewatch.com/company/adjucor, updated 29 December 2024. When citing, please name BounceWatch and link this page.